Milagros Ramos is a researcher at the Center for Biomedical Technology (CTB) and an associate professor in the Department of Photonic Technology and Bioengineering at the UPM. She holds a bachelor's degree in biological sciences from UCM and a Ph.D. in sciences from Universidad Autónoma de Madrid, specializing in cell biology. During her Ph.D., she investigated various mechanisms by which guanine nucleotides protect against damage induced by glutamatergic excitotoxicity in the cerebellum. Subsequently, she conducted a postdoctoral period at the Center for Molecular Biology "Severo Ochoa" (CSIC-UAM). Her research explored their potential applications for developing cell replacement strategies for Parkinson's disease. Currently, Milagros Ramos is the Principal Investigator of the Biochemistry and Biofunctionalization group at the Center for Biomedical Technology (CTB-UPM). Her research is focused on two main areas: I) Design and synthesis of contrast agents based on magnetic nanoparticles for the early detection of Alzheimer's disease through magnetic resonance imaging. II) Induction of tumor cell death through hyperthermia using biofunctionalized gold and/or magnetic nanoparticles as antitumor agents, achieved through optical or magnetic hyperthermia, respectively. Milagros Ramos holds five patents, has authored 10 book chapters, and published over 60 papers in indexed journals, most of them (80%) published in Q1 journals.
Milagros Ramos is a researcher at the Center for Biomedical Technology (CTB) and an associate professor in the Department of Photonic Technology and Bioengineering at the UPM. She holds a bachelor's degree in biological sciences from UCM and a Ph.D. in sciences from Universidad Autónoma de Madrid, specializing in cell biology. During her Ph.D., she investigated various mechanisms by which guanine nucleotides protect against damage induced by glutamatergic excitotoxicity in the cerebellum. Subsequently, she conducted a postdoctoral period at the Center for Molecular Biology "Severo Ochoa" (CSIC-UAM). Her research explored their potential applications for developing cell replacement strategies for Parkinson's disease. Currently, Milagros Ramos is the Principal Investigator of the Biochemistry and Biofunctionalization group at the Center for Biomedical Technology (CTB-UPM). Her research is focused on two main areas: I) Design and synthesis of contrast agents based on magnetic nanoparticles for the early detection of Alzheimer's disease through magnetic resonance imaging. II) Induction of tumor cell death through hyperthermia using biofunctionalized gold and/or magnetic nanoparticles as antitumor agents, achieved through optical or magnetic hyperthermia, respectively. Milagros Ramos holds five patents, has authored 10 book chapters, and published over 60 papers in indexed journals, most of them (80%) published in Q1 journals.